The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127478121 12747812 1 I 20160527 20160915 20160915 PER US-JAZZ-2016-US-010050 JAZZ 0.00 F Y 0.00000 20160915 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127478121 12747812 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
127478121 12747812 2 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID U 21196 3 G ORAL SOLUTION
127478121 12747812 3 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, BID U 21196 3.75 G ORAL SOLUTION
127478121 12747812 4 SS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 21196 2.25 G ORAL SOLUTION
127478121 12747812 5 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID U 21196 3 G ORAL SOLUTION
127478121 12747812 6 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, BID U 21196 3.75 G ORAL SOLUTION
127478121 12747812 7 SS XYREM SODIUM OXYBATE 1 3.75 G, BID U 21196 3.75 G ORAL SOLUTION
127478121 12747812 8 SS NUVIGIL ARMODAFINIL 1 U 0
127478121 12747812 9 C EPIPEN EPINEPHRINE 1 U 0
127478121 12747812 10 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 U 0
127478121 12747812 11 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 U 0
127478121 12747812 12 C Belladonna and phenobarbitone 2 U 0
127478121 12747812 13 C FLONASE FLUTICASONE PROPIONATE 1 U 0
127478121 12747812 14 C PROVIGIL MODAFINIL 1 100 MG, UNK U 0 100 MG
127478121 12747812 15 C PROVIGIL MODAFINIL 1 200 MG, UNK U 0 200 MG
127478121 12747812 16 C RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 5 MG, UNK U 0 5 MG
127478121 12747812 17 C RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 20 MG, UNK U 0 20 MG
127478121 12747812 18 C VENTOLIN HFA ALBUTEROL SULFATE 1 U 0
127478121 12747812 19 C ADDERALL AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE 1 U 0
127478121 12747812 20 C BREO ELLIPTA FLUTICASONE FUROATEVILANTEROL TRIFENATATE 1 U 0
127478121 12747812 21 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127478121 12747812 1 Narcolepsy
127478121 12747812 8 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127478121 12747812 Drug hypersensitivity

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127478121 12747812 1 201008 201008 0
127478121 12747812 2 201008 201008 0
127478121 12747812 3 201008 2011 0
127478121 12747812 4 201307 201307 0
127478121 12747812 5 201307 201307 0
127478121 12747812 6 201307 0
127478121 12747812 7 201406 0